BIO
Leveraging differentiating expertise and resources, ReciBioPharm has established itself as a CDMO that can dramatically enhance a company’s xRNA project outcomes in terms of speed, product quality, and cost-efficiency. Through cutting-edge digital technologies, ReciBioPharm fuses process development with manufacturing, reducing the time from target sequence identification to clinical trial material readiness.